This compound is a sulfonamide derivative featuring a spirocyclic diazaspiro[4. 4]nonene core and an isoxazole moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1026355-73-6
Sparsentan
pharmaceutical raw material
N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)methylamino)propyl)formamide
pharmaceutical intermediate
Ethyl 4-{3-[2-(dimethylamino)-2-oxoethyl]-6-methylimidazo[1,2-a]pyridin-2-yl}benzoate
pharmaceutical intermediate
N-[(1R,2R)-2-Amino-1,2-diphenylethyl]-2,3,4,5,6-pentafluorobenzene-1-sulfonamide
pharmaceutical intermediate
2-Bromo-5-(trifluoromethyl)benzaldehyde
pharmaceutical intermediate
2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)-N-(methoxymethyl)benzenesulfonamide
XYWGCTPPRWEYNN-UHFFFAOYSA-N
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)N(COC)C5=NOC(=C5C)C)COCC
—